1.Alternative Name:4-1BB Ligand,TNFSF9;41BB Ligand; 4-1BB Ligand; 4-1BBL; 4-1BB-L; CD137L; homolog of mouse 4-1BB-L; receptor 4-1BB ligand; TNFSF9; tumor necrosis factor (ligand) superfamily, member 9; tumor necrosis factor ligand superfamily member 9
2.Target:CD137L
3.Source:Human CD137L was expressed from HEK293 with poly His at the C-terminal
4.Sequence:Arg71-Glu254
5.Protein structure:P41273His
6.Molecular Characterization:The protein has a calculated MW of 62kDa.The reducing (R) heterodimer protein migrates as 50-70 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 90%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 90%.

13.ELISA

When Recombinant Human CD137L /His Flag Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Recombinant Human CD137/ hFC Protein that produces 50% of the optimal binding response is approximately 40 ng/ml.